Revive Therapeutics Ltd (RVV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 218 | 335 | 481 | 289 | 544 |
| Operating Income | -218 | -335 | -481 | -289 | -544 |
| Interest Expense | 0 | 0 | 0 | 0 | 1 |
| Other Income | -64 | -9,262 | -97 | -76 | 73 |
| Pre-tax Income | -282 | -9,597 | -577 | -365 | -473 |
| Net Income Continuous | -282 | -9,597 | -577 | -365 | -473 |
| Net Income | $-282 | $-9,597 | $-577 | $-365 | $-473 |
| EPS Basic Total Ops | 0.00 | -0.03 | 0.00 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | 0.00 | -0.03 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.00 | -0.03 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | -0.03 | 0.00 | 0.00 | 0.00 |
| EBITDA(a) | $-282 | $-9,597 | $-577 | $-365 | $-472 |